Apr
4
Medting in Health 2.0 Europe
Filed Under English, Press | Leave a Comment
Medting will be present in the Health 2.0 conference taken place in Paris next april 6th and 7th. We will be in session Physicians and Online Communities presenting our platform with some other colleagues and innitiatives like:
An article in Informilo, a prestigious has been published recently by Jennifer L. Schenker. She has been covering technology outside the U.S for 23 years, most recently for BusinessWeek. She has also worked full-time for the Wall Street Journal Europe, Time Magazine, International Herald Tribune and Red Herring.
Informilo is a news site that covers tech sector developments in Europe, the Middle East, Africa, Asia Pacific and the Americas. The site covers entrepreneurship and innovation in every part of the pipeline - from the smallest start-up with the best idea to big companies that embrace creative disruption. The aim is to help start-ups and venture capitalists benchmark the global competition and connect with big corporates.
Jan
22
Medting becomes partner of Webicina
Filed Under English, Partnership | Leave a Comment
Webicina is a privately held company aiming to build a bridge between physicians and e-patients. Webicina provides services that help medical professionals and patients enter the web 2.0 era. The visionary Health 2.0 guru and expert, Bertalan Meskó, has founded this innitiativeafter seen that the number of e-patients is growing rapidly while the number of web-savvy doctors is not.
With personalized Medicine 2.0 Packages, step-by-step tutorials, webinars and online image building solutions. Webicina was designed to help physicians from all the medical specialties and patients as well to get closer to the web 2.0 based world.
Medting has supported the innitiative from the begining. The need of trainned doctors about the internet and web 2.0 is a big issue and Medting can offer a good clinical service to doctors that can also realize about the benefits and potentials of the new internet.
For that reason Medting has become Webicina partner and will be one of the platforms and services included in the Webicina packages.
If you are a doctor, hospital, healthcare organization and even a patient willing to understand how web 2.0 can bring value to healthcare go to Webicina and request for one training package for you.
Oct
7
Medting is developing an innovative advertising scheme that would serve to sustain the website but could also benefit non-profit organizations by providing a source of funding.
Very basically described, we are thinking in putting advertising (an sponsor logo) for each image or clinical case. The sponsorship income is going to be co-shared between Medting and the owner of the case / image.
Our difference is that the Doctor is going to select the advertising company he wants to show. That means that the doctor can directly arrange with any sponsor for putting images or cases in Medting. Medting would take a fee from that posting.
There is also another scenario more for the non-Profit organizations. A doctor can post a case and say that he wants to collaborate with a Non-Profit Program or Institution. In that case Medting or the Institution will select the advertising company. It’s a way where Non profit institutions may get some funding for their innitiatives, humanitarian help or research activities. Also the sponsor could be the Foundation or Association to get the interest of searching patients.
These are new revenue models we are thinking. The win-win relationship and the possibility to help for the global health innitiatives development is quite exciting for Medting Team.
Before moving forward with this idea we would like to get the input from our community and see how this could be preceived. We now adversiting in healthcare is a delicated topic but doing it in a relationship where all the involved agents win is definetly something for all to consider. Moreover where the real winner is healthcare since the more knowledgement we interchange the faster we get medical advances.
Please include your comments for our discussion.